Difference between revisions of "Template:Glutamate receptor modulators"

From blackwiki
Jump to navigation Jump to search
imported>Medgirl131
imported>Medgirl131
Line 83: Line 83:
 
* [[Talampanel]]
 
* [[Talampanel]]
  
   | group2 = {{abbrlink|NMDAR|N-Methyl-D-aspartate receptor}}
+
   | group2 = {{abbrlink|Kainate|Kainate receptor}}
 
   | list2 =
 
   | list2 =
 +
* '''Agonists:''' ''Glutamate/active site  agonists:'' [[5-Bromowillardiine]]
 +
* [[5-Iodowillardiine]]
 +
* [[Acromelic acid|Acromelic acid (acromelate)]]
 +
* [[AMPA]]
 +
* [[ATPA]]
 +
* [[Domoic acid]]
 +
* [[Glutamate]]
 +
* [[Ibotenic acid]]
 +
* [[Kainic acid]]
 +
* [[LY-339,434]]
 +
* [[Proline]]
 +
* [[Quisqualic acid]]
 +
* [[SYM-2081]]; ''Positive allosteric modulators:'' [[Cyclothiazide]]
 +
* [[Diazoxide]]
 +
* [[Enflurane]]
 +
* [[Halothane]]
 +
* [[Isoflurane]]
 +
 +
* '''Antagonists:''' [[ACEA-1011]]
 +
* [[CNQX]]
 +
* [[Dasolampanel]]
 +
* [[DNQX]]
 +
* [[gamma-D-Glutamylaminomethylsulfonic acid|GAMS]]
 +
* [[Kaitocephalin]]
 +
* [[Kynurenic acid]]
 +
* [[Licostinel|Licostinel (ACEA-1021)]]
 +
* [[LY-382,884]]
 +
* [[NBQX]]
 +
* [[NS102]]
 +
* [[Selurampanel]]
 +
* [[Tezampanel]]
 +
* [[Theanine]]
 +
* [[Topiramate]]
 +
* [[UBP-302]]; ''Negative allosteric modulators:'' [[Barbiturates]] (e.g., [[pentobarbital]], [[sodium thiopental]])
 +
* [[Enflurane]]
 +
* [[Ethanol]]
 +
* [[Evans blue]]
 +
* [[NS-3763]]
 +
* [[Pregnenolone sulfate]]
 +
 +
  | group3 = {{abbrlink|NMDAR|N-Methyl-D-aspartate receptor}}
 +
  | list3 =
 
* '''Agonists:''' ''Glutamate/active site  agonists:'' [[2-Amino-2-(3-hydroxy-5-methylisoxazol-4-yl)acetic acid|AMAA]]
 
* '''Agonists:''' ''Glutamate/active site  agonists:'' [[2-Amino-2-(3-hydroxy-5-methylisoxazol-4-yl)acetic acid|AMAA]]
 
* [[Aspartate]]
 
* [[Aspartate]]
Line 286: Line 328:
 
* [[Trichloroethylene]]
 
* [[Trichloroethylene]]
 
* [[Xylene]]
 
* [[Xylene]]
 
  | group3 = {{abbrlink|Kainate|Kainate receptor}}
 
  | list3 =
 
* '''Agonists:''' ''Glutamate/active site  agonists:'' [[5-Bromowillardiine]]
 
* [[5-Iodowillardiine]]
 
* [[Acromelic acid|Acromelic acid (acromelate)]]
 
* [[AMPA]]
 
* [[ATPA]]
 
* [[Domoic acid]]
 
* [[Glutamate]]
 
* [[Ibotenic acid]]
 
* [[Kainic acid]]
 
* [[LY-339,434]]
 
* [[Proline]]
 
* [[Quisqualic acid]]
 
* [[SYM-2081]]; ''Positive allosteric modulators:'' [[Cyclothiazide]]
 
* [[Diazoxide]]
 
* [[Enflurane]]
 
* [[Halothane]]
 
* [[Isoflurane]]
 
 
* '''Antagonists:''' [[ACEA-1011]]
 
* [[CNQX]]
 
* [[Dasolampanel]]
 
* [[DNQX]]
 
* [[gamma-D-Glutamylaminomethylsulfonic acid|GAMS]]
 
* [[Kaitocephalin]]
 
* [[Kynurenic acid]]
 
* [[Licostinel|Licostinel (ACEA-1021)]]
 
* [[LY-382,884]]
 
* [[NBQX]]
 
* [[NS102]]
 
* [[Selurampanel]]
 
* [[Tezampanel]]
 
* [[Theanine]]
 
* [[Topiramate]]
 
* [[UBP-302]]; ''Negative allosteric modulators:'' [[Barbiturates]] (e.g., [[pentobarbital]], [[sodium thiopental]])
 
* [[Enflurane]]
 
* [[Ethanol]]
 
* [[Evans blue]]
 
* [[NS-3763]]
 
* [[Pregnenolone sulfate]]
 
  
 
  }}
 
  }}

Revision as of 09:25, 27 August 2017

Initial visibility: currently defaults to autocollapse

To set this template's initial visibility, the |state= parameter may be used:

  • |state=collapsed: {{Glutamate receptor modulators|state=collapsed}} to show the template collapsed, i.e., hidden apart from its title bar
  • |state=expanded: {{Glutamate receptor modulators|state=expanded}} to show the template expanded, i.e., fully visible
  • |state=autocollapse: {{Glutamate receptor modulators|state=autocollapse}}
    • shows the template collapsed to the title bar if there is a {{navbar}}, a {{sidebar}}, or some other table on the page with the collapsible attribute
    • shows the template in its expanded state if there are no other collapsible items on the page

If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.